PPARα activation can help prevent and treat non-small cell lung cancer

Non-small cell lung cancer (NSCLC) not amenable to surgical resection has a high mortality rate, due to the ineffectiveness and toxicity of chemotherapy. Thus, there remains an urgent need of efficacious drugs that can combat this disease. In this study, we show that targeting the formation of pro-a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Skrypnyk, Nataliya, Chen, Xiwu, Hu, Wen, Su, Yan, Mont, Stacey, Yang, Shilin, Gangadhariah, Mahesha, Wei, Shouzuo, Falck, John R., Jat, Jawahar Lal, Zent, Roy, Capdevila, Jorge H., Pozzi, Ambra
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3902646/
https://ncbi.nlm.nih.gov/pubmed/24302581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-1928
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars